MediPharm Labs Corp.

MediPharm Labs Corp.

Offering international quality standards to the Cannabis Industry with our purified cannabis concentrates.
1d 5d 1m 6m 1y Max

MediPharm Labs Corp. News

About MediPharm Labs Corp.

A leader in cannabis extraction and purification, MediPharm Labs has invested in an expert team, state-of-the-art technology, advanced methodologies and a purpose-built facility to deliver pure, safe and precisely-dosed cannabis concentrates and advanced derivative products.

MediPharm's state-of-the-art facility is in compliance with European current Good Manufacturing Practices (cGMP) requirements and designed to ISO standard cleanrooms and critical environments. The standard of design and construction are currently the most innovative and technically advanced in the Canadian cannabis industry.

These pharma-grade critical environments combined with our discipline and proprietary methodologies result in repeatability in manufacturing, precision dosing, and purity assurance. These foundations of our organization ultimately deliver trusted, safe products for patients or end consumers.

Founded in 2015, MediPharm Labs Inc. is a pioneer in the cannabis industry and has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the Access to Cannabis for Medical Purposes Regulations (ACMPR) without first receiving a cannabis cultivation license. This expert focus on cannabis concentrates from our cGMP (current Good Manufacturing Practices) and ISO standard clean rooms and critical environments laboratory, allows MediPharm to work with its established, Health Canada-approved cultivation partners to produce pharmaceutical-grade cannabis oil with a competitive advantage. MediPharm is research-driven and focused on downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification.


Pat McCutcheon
President, CEO & Chairman of the Board
Keith Strachan
Vice President & Director
David Mayers
Chief Operating Officer
Ahmed Shehata
General Counsel and Head of Corporate Development...
Chris Hobbs
Chief Financial Officer & Director
Jason Nalewany
Vice President, Finance
Sybil Taylor
Chief Marketing Officer
Laura Lepore
VP Investor Relations & Communications
Paul Hamelin
Director of Security
Dr. Chris Talpas
Director of Quality Control and Assurance
Dr. Ina Dubinsky
Lead Scientist – Secondary Processing
Warren Everitt
Director, MediPharm Labs Australia
Jake Golding
Director of Quality - Australia
Anuja Siwakoti
Director of Global Regulatory and Scientific Affai...
Lorna Willner
Director of Human Resources
Saravan Subramaniam
Director, Project Management Office
Mike Perron
Director of Global Business Development

Participation in events

$ 25.69